Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: a prospective randomized trial.

[1]  B. Jeremic,et al.  Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small-cell lung cancer: a randomized study. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  J. Armand,et al.  Intensive concomitant chemoradiotherapy in locally advanced unresectable squamous cell carcinoma of the head and neck: a phase II study of radiotherapy with cisplatin and 7-week continuous infusional fluorouracil. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  W. Panje,et al.  Induction chemotherapy followed by concomitant chemoradiotherapy for advanced head and neck cancer: impact on the natural history of the disease. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  S. Lippman,et al.  Head and Neck Cancer , 1993, Cancer Treatment and Research.

[5]  G. Slotman,et al.  Concurrent cis-platinum and radiation with or without surgery for advanced head and neck cancer. , 1994, International journal of radiation oncology, biology, physics.

[6]  R. Weichselbaum,et al.  Intensified concomitant chemoradiotherapy with and without filgrastim for poor-prognosis head and neck cancer. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  C. Kolotas,et al.  Carboplatin and radiotherapy in the treatment of head and neck cancer: six years' experience. , 1994, Seminars in oncology.

[8]  M. Milella,et al.  A randomized phase II study comparing sequential versus simultaneous chemo-radiotherapy in patients with unresectable locally advanced squamous cell cancer of the head and neck. , 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  P. McLaughlin,et al.  Intensive induction chemotherapy and radiation for organ preservation in patients with advanced resectable head and neck carcinoma. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  S. Papaspyrou,et al.  Radiation therapy and concurrent cisplatin administration in locally advanced head and neck cancer. A Hellenic Co-operative Oncology Group study. , 1994, Acta oncologica.

[11]  R. Orecchia,et al.  Concomitant radiotherapy and daily low-dose carboplatin in locally advanced, unresectable head and neck cancer. Definitive results of a phase I-II study. , 1994, Acta oncologica.

[12]  M. Eisenberger,et al.  Simultaneous treatment with single-agent chemotherapy and radiation for locally advanced cancer of the head and neck. , 1992, Seminars in oncology.

[13]  G. Gasparini,et al.  Synchronous Radiotherapy and Chemotherapy with Cisplatin in the Management of Locally Advanced or Recurrent Head and Neck Cancer , 1992, American journal of clinical oncology.

[14]  H. Bartelink,et al.  Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. , 1992, The New England journal of medicine.

[15]  K. Fu,et al.  Biologic rationale of combined radiotherapy and chemotherapy. , 1991, Hematology/oncology clinics of North America.

[16]  R. Crooijmans,et al.  Effectiveness in inhibition of recovery of cell survival by cisplatin and carboplatin: influence of treatment sequence. , 1991, International journal of radiation oncology, biology, physics.

[17]  S. Macphail,et al.  Interaction of platinum drugs with clinically relevant x-ray doses in mammalian cells: a comparison of cisplatin, carboplatin, iproplatin, and tetraplatin. , 1991, International journal of radiation oncology, biology, physics.

[18]  R. Müller,et al.  Carboplatin plus radiation therapy in head and neck cancer. , 1991, Seminars in oncology.

[19]  W. Curran,et al.  Elapsed treatment days--a critical item for radiotherapy quality control review in head and neck trials: RTOG report. , 1991, International journal of radiation oncology, biology, physics.

[20]  W. Curran,et al.  Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck. Long‐term results of the radiation therapy oncology group study 81‐17 , 1990, Cancer.

[21]  R. Weichselbaum,et al.  Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumors. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  M. Eisenberger,et al.  Carboplatin (CBDCA) and radiotherapy for stage IV carcinoma of the head and neck: a phase I-II study. , 1989, International journal of radiation oncology, biology, physics.

[23]  S. Rockwell,et al.  Randomized clinical trial of mitomycin C as an adjunct to radiotherapy in head and neck cancer. , 1989, International journal of radiation oncology, biology, physics.

[24]  F. Muggia.  Overview of carboplatin: replacing, complementing, and extending the therapeutic horizons of cisplatin. , 1989, Seminars in oncology.

[25]  M. Posner,et al.  Pharmacokinetic and toxicity evaluation of five-day continuous infusion versus intermittent bolus cis-diamminedichloroplatinum(II) in head and neck cancer patients. , 1988, Cancer research.

[26]  F. Eschwège,et al.  Ten-year results of randomized trial comparing radiotherapy and concomitant bleomycin to radiotherapy alone in epidermoid carcinomas of the oropharynx: experience of the European Organization for Research and Treatment of Cancer. , 1988, NCI monographs : a publication of the National Cancer Institute.

[27]  K. Fu,et al.  Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: update of a Northern California Oncology Group randomized trial. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  J. Tobias,et al.  Concurrent daily cisplatin and radiotherapy in locally advanced squamous carcinoma of the head-and-neck and bronchus. , 1987, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[29]  R. Donehower,et al.  Carboplatin (NSC-241-240): an active platinum analog for the treatment of squamous-cell carcinoma of the head and neck. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  H. Bartelink,et al.  Therapeutic enhancement in mice by clinically relevant dose and fractionation schedules of cis-diamminedichloroplatinum (II) and irradiation. , 1986, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[31]  E. Douple,et al.  Carboplatin as a potentiator of radiation therapy. , 1985, Cancer treatment reviews.

[32]  T. Pajak,et al.  Radiation therapy alone or in combination with surgery in head and neck cancer , 1985, Cancer.

[33]  L. Freedman.  Tables of the number of patients required in clinical trials using the logrank test. , 1982, Statistics in medicine.

[34]  S. Stefani,et al.  Hydroxyurea and radiotherapy in head and neck cancer — Long term results of a double blind randomized prospective study , 1980 .

[35]  G. Ramírez,et al.  Combined radiation therapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx: a randomized study. , 1976, AJR. American journal of roentgenology.